Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 5—May 2025
Research Letter
Clinical and Epidemiologic Characteristics of Mpox Cases, Dominican Republic, July 2022–February 2023
Table
Clinical and epidemiologic characteristics of suspected mpox cases in the Dominican Republic, July 2022–February 2023*
Patient characteristics | Confirmed cases | Negative cases |
---|---|---|
Total |
71 (100.0) |
212 (100.0) |
Sex | ||
M | 48 (67.6) | 124 (58.5) |
F |
23 (32.4) |
88 (41.5) |
Age range, y | ||
0–9 | 16 (22.5) | 55 (25.9) |
10–19 | 6 (8.5) | 22 (10.4) |
20–29 | 19 (26.8) | 41 (19.3) |
30–39 | 16 (22.5) | 45 (21.2) |
40–49 | 4 (5.6) | 15 (7.1) |
50–59 | 7 (9.9) | 15 (7.1) |
>60 |
3 (4.2) |
19 (9.0) |
Country of birth | ||
Dominican Republic | 68 (95.8) | 202 (95.3) |
Other† |
3 (4.2) |
10 (4.7) |
Highest education level | ||
None | 10 (14.1) | 38 (17.9) |
Elementary school | 8 (11.3) | 23 (10.9) |
Middle school | 7 (9.9) | 17 (8.0) |
High school | 14 (19.7) | 47 (22.2) |
College or technical school | 11 (15.5) | 24 (11.3) |
Missing |
21 (29.6) |
63 (29.7) |
Health region of residence | ||
I Valdesia | 13 (18.3) | 19 (9.0) |
II Cibao Norte | 11 (15.5) | 25 (11.8) |
III Cibao Nordeste | 0 | 11 (5.2) |
IV Enriquillo | 0 | 10 (4.7) |
O Metropolitana | 39 (54.9) | 122 (57.5) |
V Este | 6 (8.5) | 11 (5.2) |
VI Del Valle | 0 | 2 (0.9) |
VII Cibao Occidental | 1 (1.4) | 9 (4.2) |
VIII Cibao Central |
1 (1.4) |
3 (1.4) |
Health insurance type | ||
Private | 23 (32.4) | 55 (25.9) |
Government subsidized | 8 (11.3) | 20 (9.4) |
No reported insurance | 11 (15.5) | 53 (25.0) |
Unknown |
29 (40.8) |
84 (39.6) |
Time from symptom onset to seeking care, d (range) |
5.0 (2.5–7.0) |
4.0 (2.0–7.0) |
Underlying illness | ||
Chronic diseases‡ | 5 (7.0) | 8 (3.8) |
HIV/AIDS | 7 (9.9) | 3 (1.4) |
Malnutrition | 0 (0.0) | 2 (0.9) |
Obesity/overweight | 0 (0.0) | 3 (1.4) |
None | 29 (40.8) | 99 (46.7) |
Missing | 30 (42.3) | 97 (45.8) |
*Values are no. (%) except as indicated. †Includes Germany, Belgium, United States, Haiti, Italy, Democratic Republic of Congo, Switzerland, and Venezuela. ‡Includes diabetes, chronic respiratory disease, hypertension, or other cardiovascular disease.
Page created: March 07, 2025
Page updated: March 17, 2025
Page reviewed: March 17, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.